Clover Health Investments, Corp.
CLOV Nasdaq
SEC CIK 1801170
Follow Clover Health Investments, Corp.
Weekly email: filings, results
Revenue, last quarter
$759.3M
+52.9% vs same quarter last year
Net income
$6.4M
+126.4% vs same quarter last year
EPS, diluted
$0.01
+120% vs same quarter last year
Operating cash flow
$70.4M
+481.5% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $1.9B | −$85.5M |
| FY24 | $1.4B | −$43M |
| FY23 | $1.3B | −$213.4M |
| FY22 | $1.1B | −$338.8M |
| FY21 | $1.5B | −$587.8M |
| FY20 | $672.9M | −$136.4M |
| FY19 | $462.3M | −$363.7M |
| FY18 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | - | −4.4% | −4.4% |
| FY24 | - | −3.3% | −3.1% |
| FY23 | 20.4% | −16.3% | −16.9% |
| FY22 | 6.4% | −26.1% | −30.9% |
| FY21 | −5.4% | −43.3% | −39.9% |
| FY20 | - | −13.8% | −20.3% |
| FY19 | - | −39.6% | −78.7% |
| FY18 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$69M |
| FY24 | $33.3M |
| FY23 | −$145.2M |
| FY22 | −$208.4M |
| FY21 | −$283M |
| FY20 | −$119.2M |
| FY19 | −$159.9M |
| FY18 | - |
Show the numbers
| Year | Buybacks |
|---|---|
| FY25 | $18.3M |
| FY24 | $1.8M |
| FY23 | $0 |
| FY22 | $0 |
| FY21 | $147K |
| FY20 | $0 |
| FY19 | $0 |
| FY18 | - |
- Clover Health Investments, Corp.
- Financials median
Show the numbers
| Year | Clover Health Investments, Corp. | Financials median |
|---|---|---|
| FY25 | −4.4% | 12.6% |
| FY24 | −3.1% | 13.7% |
| FY23 | −16.9% | 11.5% |
| FY22 | −30.9% | 12.8% |
| FY21 | −39.9% | 18.9% |
| FY20 | −20.3% | 13.3% |
| FY19 | −78.7% | 14.4% |
| FY18 | - | 17.2% |